Valuation: ResMed, Inc.

Market Cap 2.94TCr 2.57TCr 2.37TCr 2.19TCr 4.16TCr 2,80500Cr 4.23TCr 28TCr 11TCr 1,38200Cr 11TCr 11TCr 4,75000Cr P/E 2026 *
19.3x
P/E 2027 * 18.1x
Enterprise Value 2.86TCr 2.5TCr 2.3TCr 2.13TCr 4.04TCr 2,72400Cr 4.11TCr 28TCr 11TCr 1,34200Cr 11TCr 10TCr 4,61300Cr EV / Sales 2026 *
5.05x
EV / Sales 2027 * 4.66x
Free-Float
75.61%
Yield 2026 *
1.19%
Yield 2027 * 1.3%
1 day-2.20%
1 week-2.75%
Current month+4.61%
1 month+5.32%
3 months-10.92%
6 months-19.25%
Current year-15.36%
1 week 203.4
Extreme 203.4
222.43
1 month 184.65
Extreme 184.65
222.43
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Chief Tech/Sci/R&D Officer - 03/01/2017
Director TitleAgeSince
Chairman 53 25/01/2023
Director/Board Member 78 01/01/2005
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
07/07Fiscal year

Chief Executive Officer

14,973 0.0103%
08/06Fiscal year

Chief Executive Officer

14,973 0.0103%
01/06Tax

General Counsel

-269 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-2.20%-2.75%-21.00%-5.88% 3.01TCr
+0.45%+0.69%+22.36%+1.97% 19TCr
-1.16%-4.51%-22.67%+19.55% 15TCr
+1.57%+0.57%-3.14%-15.11% 14TCr
-0.49%-0.82%-56.89%-15.05% 6.69TCr
+0.96%-2.29%+17.02%+0.62% 5.26TCr
+0.61%-1.09%-27.71%-30.42% 4.38TCr
+0.52%+2.75%+8.15%+13.46% 3.77TCr
-0.19%-0.75%+6.55%+42.23% 3.7TCr
0.00%-1.32%-15.42%-19.79% 2.94TCr
Average +0.41%-0.92%-9.28%-0.84% 7.77TCr
Weighted average by Cap. +0.71%-0.84%-5.20%+0.18%

Financials

2026 *2027 *
Net sales 565.03Cr 494.23Cr 455.87Cr 421.04Cr 798.91Cr 54TCr 812.35Cr 5.45TCr 2.14TCr 27TCr 2.12TCr 2.08TCr 91TCr 596.88Cr 522.1Cr 481.57Cr 444.77Cr 843.95Cr 57TCr 858.14Cr 5.75TCr 2.26TCr 28TCr 2.24TCr 2.19TCr 96TCr
Net income 154.8Cr 135.4Cr 124.89Cr 115.35Cr 218.87Cr 15TCr 222.55Cr 1.49TCr 585.99Cr 7.27TCr 581.21Cr 568.56Cr 25TCr 164.77Cr 144.12Cr 132.93Cr 122.78Cr 232.97Cr 16TCr 236.89Cr 1.59TCr 623.74Cr 7.74TCr 618.65Cr 605.19Cr 27TCr
Net Debt -85Cr -74Cr -69Cr -63Cr -120.06Cr -8.1TCr -122.08Cr -818.52Cr -321.44Cr -3.99TCr -318.81Cr -311.88Cr -14TCr -158.8Cr -138.9Cr -128.12Cr -118.33Cr -224.53Cr -15TCr -228.31Cr -1.53TCr -601.16Cr -7.46TCr -596.26Cr -583.28Cr -26TCr
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
10/26/10 $203.87 -2.20% 13,31,127
09/26/09 $208.45 +1.27% 14,79,036
08/26/08 $205.84 -6.33% 17,61,755
07/26/07 $219.75 +0.62% 17,26,352
06/26/06 $218.40 +4.18% 37,22,027
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
203.87USD
Average target price
256.07USD
Spread / Average Target
+25.60%

Quarterly revenue - Rate of surprise